Mepolizumab for severe asthma flare-ups after treatment
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial studies whether mepolizumab can reduce ongoing or returning asthma flare-ups in people with severe asthma. If you have severe asthma that still keeps flaring, this may help by targeting a specific inflammation pathway involved in some asthma cases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a proven diagnosis of severe asthma (as defined by the Canadian Thoracic Society).
- Your doctor says you’re eligible to receive mepolizumab.
- You can and are willing to sign the informed consent form.
- You do not have any lung or breathing disease other than asthma.
- You do not have certain related conditions (like EGPA or hypereosinophilic syndrome).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and other measures (biomarkers) to understand how well mepolizumab helps people with nasal polyps, with or without asthma. It aims to find response clues that could help personalize treatment in the future.
This trial tests reslizumab, a medicine that targets a specific immune signal, to improve symptoms in people with eosinophilic granulomatosis with polyangiitis (EGPA). It may help lower disease activity and reduce inflammation-related problems.
This study aims to improve care for people with asthma who are at higher risk of severe flare-ups. It may test new ways to manage asthma and help you avoid hospital visits.
This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.
This study tests a new approach to reduce flare-ups (sudden worsening of symptoms) in people with COPD. If you've had frequent flare-ups, this trial may help you manage your condition better.
This study tests a medication called mepolizumab (given as an injection) in people with COPD who have high eosinophils and frequent flare-ups. The goal is to see if it reduces inflammation and helps them breathe better, by looking at airway changes with special scans.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.